We are live on ! Find out more
INM icon

InMed Pharmaceuticals
INM

15 hedge funds and large institutions have $1.55M invested in InMed Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,025% more capital invested

Capital invested by funds: $138K → $1.55M (+$1.41M)

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

50% more funds holding

Funds holding: 10 → 15 (+5)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.01M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$691K
3
Citadel Advisors
Citadel Advisors
Florida
+$72.9K
4
Morgan Stanley
Morgan Stanley
New York
+$23.6K
5
Bank of America
Bank of America
North Carolina
+$15K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.15K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$776K +$1.01M +470 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$531K +$691K +322 New
Citadel Advisors
3
Citadel Advisors
Florida
$57K +$72.9K +34 New
Bank of America
4
Bank of America
North Carolina
$53K +$15K +7 +28%
Morgan Stanley
5
Morgan Stanley
New York
$41K +$23.6K +11 +79%
Creative Planning
6
Creative Planning
Kansas
$36K – – –
JP Morgan Chase
7
JP Morgan Chase
New York
$36K +$4.29K +2 +15%
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$6K – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$4K – – –
UBS Group
10
UBS Group
Switzerland
$3K +$4.29K +2 New
AWM
11
AllSquare Wealth Management
New York
$2K – – –
RFA
12
Reilly Financial Advisors
California
$2K +$2.15K +1 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$2K +$2.15K +1 New
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$1K -$2.15K -1 Closed
FF
15
FourThought Financial
Florida
$1K – – –
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
$962 – – –

INM Hedge Fund Activity: Q1 2021 in Review

15 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in InMed Pharmaceuticals (INM) for Q1 2021, worth a combined $1.55M — up 1,025% from $138K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new INM positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.01M. The largest seller was Bank of Montreal, exiting entirely with an estimated $2.15K sold.

  • 15 institutional investors held InMed Pharmaceuticals (INM) as of Q1 2021, up from 10 in Q4 2020.
  • Funds reported $1.55M of InMed Pharmaceuticals stock for Q1 2021, up 1,025% quarter-over-quarter.
  • 6 funds opened new InMed Pharmaceuticals positions in Q1 2021 and 1 closed out, a net change of +5 holders.
  • The largest InMed Pharmaceuticals buyer in Q1 2021 was Armistice Capital, an estimated $1.01M added.
  • The largest InMed Pharmaceuticals seller in Q1 2021 was Bank of Montreal, an estimated $2.15K sold.

Based on aggregated 13F filings for Q1 2021.